Most brand strategies fail because the underlying business problem has not been diagnosed. Strategy begins with diagnosis.
Without diagnosis, brand strategy is just activity.
In 1943, the US military asked Abraham Wald where to add armour to their bombers. The planes returning from combat were covered in bullet holes, concentrated in the fuselage and wings. The officers wanted to reinforce those areas. Wald said the opposite. Reinforce the engines and cockpit. The planes hit there weren't coming back.
The data was real. The diagnosis was backwards.
Most businesses make the same error with brand. This is the idea behind The Value Inversion: that value creation increasingly depends on diagnosing structural constraints rather than executing faster, spending more, or rebranding louder.
The core idea
Most brand investment fails because the business has not diagnosed the real problem. Companies see flat growth or weak pricing power and respond with marketing activity: a rebrand, a new campaign, more media spend. But brand is not primarily a marketing asset. It is the expression of how a business creates and delivers value. If the product promise, customer experience, and positioning are misaligned, brand investment amplifies the problem rather than solving it.
The pattern repeats: flat revenue triggers a rebrand, the rebrand changes nothing, because the structural constraint was never identified. Weak pricing power triggers a campaign, the campaign generates impressions but no margin improvement, because the value proposition doesn't hold up at the point of contact.
Strategy begins with diagnosis. Without it, brand strategy is just activity.
Why the rebrand didn't work
A portfolio company is 18 months from exit. Revenue is flat. The board hires a new CMO, commissions a rebrand and a new brand platform, and increases performance marketing spend. Twelve months later, nothing material has changed. The new logo is fine. The ads are running. The revenue is still flat.
The problem wasn't the brand identity or the media budget. The company's product promise and its customer experience were misaligned, and that misalignment was suppressing pricing power. No rebrand fixes that. No amount of paid media compensates for a value proposition that breaks at the point of contact.
They diagnosed the visible damage and missed the structural failure. This is not the exception. It's the default.
What bad strategy looks like
Richard Rumelt identifies four hallmarks of bad strategy. They show up in PE portfolios with striking regularity.
Fluff: words that sound strategic but mean nothing. Brand purpose statements are the usual vehicle. "We exist to empower communities through innovation" tells you nothing about what the business does, who it serves, or what trade-offs it's willing to make.
Failure to face the challenge. The real issue is that the product is undifferentiated or the market has shifted. But the strategy deck describes the aspiration without confronting the obstacle.
Mistaking goals for strategy. "Grow revenue 30%" is a goal. It identifies no lever, no structural advantage, no point of concentration. It is a wish dressed as a plan.
Bad strategic objectives: a long, incoherent list of initiatives that pull in different directions. No prioritisation. No sequence. The organisation tries to do twelve things, commits to none, and achieves nothing of consequence.
The kernel
Good strategy has three parts. Rumelt calls it the kernel.
A diagnosis that defines the challenge. Not a restatement of the goal. A clear articulation of the specific structural problem. "We are integrated around hardware when the market has moved to solutions" is a diagnosis. "We need to grow" is not.
A guiding policy that narrows the field. One strategic direction that rules out alternatives and concentrates effort.
A set of coherent actions where each move reinforces the others. Not a list of initiatives. A coordinated system.
It works the same way a doctor works. Symptoms lead to diagnosis. Diagnosis leads to a therapeutic approach. The approach leads to prescriptions. You wouldn't accept a prescription from a doctor who skipped the diagnosis. But businesses accept brand strategies built on the same omission every day.
Chain-link logic
In any system, the weakest link determines the strength of the whole chain. Strengthening strong links while the weak one remains does nothing.
Applied to brand: if the promise is strong but the customer experience breaks it at delivery, investing more in awareness makes things worse. You're raising expectations the business cannot meet. Every additional impression accelerates the damage. Rebrands fail when they change visual identity but leave the underlying value proposition unchanged.
An Italian engineering firm found that its machines were excellent but its sales process was undermining the quality. The fix wasn't better machines. It was bringing sales into the same quality discipline the engineering team already used. The chain got stronger at its weakest point.
The diagnosis has to find the weak link before any investment decision is made.
The pivotal factor
The most powerful element of a real diagnosis is what Rumelt calls the pivotal factor: the single insight that, if acted on, changes the trajectory.
Sam Walton's pivotal factor was not low prices. It was the redefinition of what a store is. Not an individual unit but a node in a network. Logistics, data flows, distribution centres, manager rotation: designed as a coherent whole. The advantage lived in the system, not the unit.
For brand strategy, the pivotal factor is often hiding in plain sight. The business has pricing power in one segment but dilutes it chasing volume in three others. The strongest customer relationship is with a cohort nobody has noticed. The product's actual differentiation has nothing to do with what the brand communicates.
Finding it requires looking at the business the way Wald looked at the bombers. Not at what's visible. At what's missing.
What this means for brand investment
Most brand strategy starts with the answer: the creative brief, the agency pitch, the campaign. Strategy starts with the question. What is actually going on here? Where is the structural problem? What is the one move that would create the most disproportionate return?
The businesses that answer these questions before they spend are the ones that compound value. The ones that skip the diagnosis and jump to execution change their logo every three years and wonder why nothing moves.
Without diagnosis, brand strategy is just activity.